HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Limited Brands Reorganization Aims To Accelerate Growth

This article was originally published in The Rose Sheet

Executive Summary

Limited Brands is reorganizing the company into three business groups - beauty and personal care, lingerie and apparel - in an effort to drive future growth, the Columbus, Ohio company announced Jan. 18

You may also be interested in...



Mark

Claudia Poccia is appointed president of Avon's teen targeted cosmetics brand, effective Nov. 1, firm reports. Exec replaces Deborah Fine, who departed mark in January to head Limited Brands' Pink division (1"The Rose Sheet" Jan. 24, 2005, p. 8). Poccia will "lead mark's continuing growth in the United States and spearhead mark's international rollout," Avon says. She will report to Executive VP and President North America Brian Connolly. Poccia previously served as senior VP and general manager of Estee Lauder's Stila brand, where she helped improve the line's visibility with 17-34 year olds, according to Avon. Appointment marks exec's second position with Avon; she was director of field marketing from 1992-1994 before joining Estee Lauder. She also has worked at Giorgio Bevery Hills and L'Oréal...

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012765

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel